Search Results
Nov 11, 2025, 16:05 ET 10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the Wolfe Research
More news about: 10x Genomics, Inc.
Nov 06, 2025, 16:05 ET 10x Genomics Reports Third Quarter 2025 Financial Results
PLEASANTON, Calif., Nov. 6, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September 30, 2025.
More news about: 10x Genomics, Inc.
Oct 29, 2025, 09:45 ET Soaring Prices and Relentless Buying Create Perfect Storm for Gold Miners
positioned in historically productive gold districts: GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF), Torex Gold Resources Inc. (TSX: TXG) (OTCQX: TORXF), GoldQuest Mining Corp. (TSXV: GQC), White Gold Corp. (TSXV: WGO) (OTCQX: WHGOF), and Hycroft Mining Holding Corporation
More news about: USA News Group
Oct 29, 2025, 09:00 ET 10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research
PLEASANTON, Calif., Oct. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of the next generation of its high-performance Flex assay, featuring automation-compatible
More news about: 10x Genomics, Inc.
Oct 20, 2025, 12:30 ET 10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, and Anthropic, an AI safety and research company and creator of Claude, today announced a collaboration
More news about: 10x Genomics, Inc.
Oct 09, 2025, 16:05 ET 10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the third quarter ended September 30, 2025 after market
More news about: 10x Genomics, Inc.